ePrints

Altered tryptophan metabolism as a paradigm for good and bad aspects of immune privilege in chronic inflammatory diseases

Lookup NU author(s): Dr Lei HuangORCiD, Dr Henrique De Paula LemosORCiD, Emeritus Professor Andrew MellorORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

The term “immune privilege” was coined to describe weak immunogenicity (hypo-immunity) that manifests in some transplant settings. We extended this concept to encompass hypo-immunity that manifests at local sites of inflammation relevant to clinical diseases. Here, we focus on emerging evidence that enhanced tryptophan catabolism is a key metabolic process that promotes and sustains induced immune privilege, and discuss the implications for exploiting this knowledge to improve treatments for hypo-immune and hyper-immune syndromes using strategies to manipulate tryptophan metabolism.

Publication metadata

Author(s): Li L, Huang L, Lemos HP, Mautino M, Mellor AL

Publication type: Article

Publication status: Published

Journal: Frontiers in Immunology

Year: 2012

Volume: 3

Issue: 109

Online publication date: 11/05/2012

ISSN (electronic): 1664-3224

Publisher: Frontiers Research Foundation

URL: https://doi.org/10.3389/fimmu.2012.00109

DOI: 10.3389/fimmu.2012.00109

PubMed id: 22593757

Altmetrics

Share